Stereotactic Body Radiotherapy for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Observational Study from a Regional Cancer Center in South Asia—A Case Series
Indian Journal of Medical and Paediatric Oncology · 20.02.2025
DOI: 10.1055/s-0045-1804503 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Medical and Paediatric Oncology, erschienen am 20.02.2025. Verfasst von Arunkumar M.N und 4 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Concurrent chemoradiation is the treatment of choice for unresectable locally advanced pancreatic cancer (LAPC). Recent progress toward an effective chemotherapeutic regime has seen improvement in systemic control; however, local control remains a significant issue. One strategy to improve local control and survival is stereotactic body radiotherapy (SBRT).
Objectives
This study aims to describe the clinical and treatment characteristics of patients with unresectable LAPC treated with SBRT and to assess the outcome. Material and Methods This is a retrospective observation study of case series involving patients treated with SBRT from January 2015 to December 2023 with unresectable LAPC. Data were recorded from the electronic medical records of the hospital-based cancer registry, and overall survival was calculated using the Statistical Package for the Social Sciences software.
Result
We enrolled four patients in this study. This group consisted of four patients with unresectable LAPC who were treated with the FOLFORINOX (folinic acid, fluorouracil, irinotecan, and oxaliplatin) chemotherapy regime followed by SBRT. For most patients, the radiotherapy dose was 30 to 40 Gy five times per week. These patients exhibited no acute or late toxicity, with 5 to 18 months overall survival.
Conclusion
Chemotherapy followed by SBRT is an effective treatment in unresectable LAPC besides chemoradiation.
Zitieren
APA
M.N, A., V., P., Selvarajan, G., Seshadri, R. A., & S., P. J. (2025). Stereotactic Body Radiotherapy for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Observational Study from a Regional Cancer Center in South Asia—A Case Series. Indian Journal of Medical and Paediatric Oncology. https://doi.org/10.1055/s-0045-1804503
Vancouver
M.N A, V. P, Selvarajan G, Seshadri RA, S. PJ. Stereotactic Body Radiotherapy for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Observational Study from a Regional Cancer Center in South Asia—A Case Series. Indian Journal of Medical and Paediatric Oncology. 2025. doi:10.1055/s-0045-1804503
BibTeX
@article{MN2025,
author = {M.N, Arunkumar and V., Priyadarshini and Selvarajan, Gangothri and Seshadri, Ramakrishnan Ayloor and S., Pradeep Jeyakumar},
title = {Stereotactic Body Radiotherapy for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Observational Study from a Regional Cancer Center in South Asia—A Case Series},
journal = {Indian Journal of Medical and Paediatric Oncology},
year = {2025},
doi = {10.1055/s-0045-1804503}
}
EUVIMED